Center-Authored Papers

Filters: Author is Wolf, Gregory T  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D
Adelstein DJ, Moon J, Hanna E, Giri SPG, Mills GM, Wolf GT, Urba SG.  2010.  Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II tria. Head & neck. 32(2):221-8. Abstract
H
Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas DA, Dunphy F, Eisele DW et al..  2015.  Head and Neck Cancers, Version 1.2015.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(7):847-56. Abstract
P
Williamson SK, Moon J, Huang CH, Guaglianone PP, LeBlanc M, Wolf GT, Urba SG.  2010.  Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(20):3330-5. Abstract
Mehta S, Moon J, Hashmi M, LeBlanc M, Huang CH, Rinehart E, Wolf GT, Urba SG, Banerjee SK, Williamson S.  2013.  Predictive factors in patients with advanced and metastatic squamous cell carcinoma of the head and neck: a study based on SWOG protocol S0420.. Oncology reports. 29(6):2095-100. Abstract